A Trial to Evaluate Safety and Tolerability of INCSHR01210 in Cancer Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This is an open-label, multicenter, non-randomized, dose escalation and tumor-expansion phase I trial to evaluate safety and tolerability of INCSHR01210 in patients with advanced solid tumors. The trial will enroll subjects with advanced solid tumor who have failed current standard anti-tumor therapies.
Epistemonikos ID: 5dcb3b53428bd27e4e196c4e01595c7c61d676ec
First added on: May 12, 2024